Astellas Pharma Inc. (TYO:4503)

Astellas Pharma Revenue

Astellas Pharma had revenue of 640.91B JPY in the quarter ending June 30, 2026, with 26.71% growth. This brings the company's revenue in the last twelve months to 2.27T, up 16.93% year-over-year. In the fiscal year ending March 31, 2026, Astellas Pharma had annual revenue of 2.14T with 11.87% growth.

• Revenue (ttm): 2.27T
• Revenue Growth: +16.93%
• P/S Ratio: 1.86
• Revenue / Employee: 161.31M
• Employees: 14,099
• Market Cap: 4.22T

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.14T	226.92B	11.87%
Mar 31, 2025	1.91T	308.65B	19.25%
Mar 31, 2024	1.60T	85.05B	5.60%
Mar 31, 2023	1.52T	222.46B	17.16%
Mar 31, 2022	1.30T	46.64B	3.73%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error